Literature DB >> 12000716

Increased angiogenesis in the bone marrow of patients with systemic mastocytosis.

Friedrich Wimazal1, John-Hendrik Jordan, Wolfgang R Sperr, Andreas Chott, Sana Dabbass, Klaus Lechner, Hans P Horny, Peter Valent.   

Abstract

Recent data suggest that angiogenesis in the bone marrow (BM) is augmented and associated with growth of neoplastic cells in various hematological malignancies. Systemic mastocytosis (SM) is a neoplasm affecting multilineage and mast cell (MC)-committed hemopoietic progenitors. In the present study, we have assessed the BM microvessel density (MVD) by CD34 immunohistochemistry in 21 patients with SM, 5 with cutaneous mastocytosis (no BM infiltrates), and 5 control cases (normal BM). The median BM MVD was significantly higher in SM compared to cutaneous mastocytosis or controls (P < 0.05). In addition, a significant correlation (r = 0.74) between the BM MVD and grade of MC infiltration (percent tryptase(+) BM infiltrates) was found in SM. Moreover, the MVD was higher in MC infiltrates compared to the nonaffected adjacent marrow (P < 0.05). Immunohistochemical staining revealed expression of vascular endothelial growth factor in MC infiltrates. The notion that SM is associated with increased BM angiogenesis and vascular endothelial growth factor expression may have implications for the biology of disease and development of new treatment strategies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12000716      PMCID: PMC1850883          DOI: 10.1016/S0002-9440(10)61111-X

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  28 in total

1.  Angiogenesis in cancer.

Authors:  O Sezer; C Jakob; K Niemöller
Journal:  J Clin Oncol       Date:  2001-07-01       Impact factor: 44.544

2.  Mast cells and mast cell neoplasia: a review.

Authors:  K Lennert; M R Parwaresch
Journal:  Histopathology       Date:  1979-09       Impact factor: 5.087

3.  Mast cell leukemia: report of a case and review of the literature.

Authors:  W D Travis; C Y Li; H C Hoagland; L B Travis; P M Banks
Journal:  Mayo Clin Proc       Date:  1986-12       Impact factor: 7.616

4.  Bone marrow findings in systemic mastocytosis.

Authors:  H P Horny; M R Parwaresch; K Lennert
Journal:  Hum Pathol       Date:  1985-08       Impact factor: 3.466

5.  Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes.

Authors:  A Aguayo; H Kantarjian; T Manshouri; C Gidel; E Estey; D Thomas; C Koller; Z Estrov; S O'Brien; M Keating; E Freireich; M Albitar
Journal:  Blood       Date:  2000-09-15       Impact factor: 22.113

Review 6.  Tissue mast cells in health and disease.

Authors:  M R Parwaresch; H P Horny; K Lennert
Journal:  Pathol Res Pract       Date:  1985-03       Impact factor: 3.250

7.  Evaluation and clinical correlations of bone marrow angiogenesis in myelofibrosis with myeloid metaplasia.

Authors:  R A Mesa; C A Hanson; S V Rajkumar; G Schroeder; A Tefferi
Journal:  Blood       Date:  2000-11-15       Impact factor: 22.113

8.  Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia.

Authors:  T Padró; S Ruiz; R Bieker; H Bürger; M Steins; J Kienast; T Büchner; W E Berdel; R M Mesters
Journal:  Blood       Date:  2000-04-15       Impact factor: 22.113

Review 9.  Pathologic fracture in systemic mastocytosis. Radiographic spectrum and review of the literature.

Authors:  M Rafii; H Firooznia; C Golimbu; E Balthazar
Journal:  Clin Orthop Relat Res       Date:  1983-11       Impact factor: 4.176

10.  Angiogenesis in myelodysplastic syndromes.

Authors:  G Pruneri; F Bertolini; D Soligo; N Carboni; A Cortelezzi; P F Ferrucci; R Buffa; G Lambertenghi-Deliliers; F Pezzella
Journal:  Br J Cancer       Date:  1999-12       Impact factor: 7.640

View more
  13 in total

1.  Identification of oncostatin M as a STAT5-dependent mediator of bone marrow remodeling in KIT D816V-positive systemic mastocytosis.

Authors:  Gregor Hoermann; Sabine Cerny-Reiterer; Andrea Perné; Miriam Klauser; Konrad Hoetzenecker; Katharina Klein; Leonhard Müllauer; Marion Gröger; Sebastian M B Nijman; Walter Klepetko; Peter Valent; Matthias Mayerhofer
Journal:  Am J Pathol       Date:  2011-03-31       Impact factor: 4.307

2.  Association of Vascular Endothelial Growth Factor A (VEGFA) and its Receptor (VEGFR2) Gene Polymorphisms with Risk of Chronic Myeloid Leukemia and Influence on Clinical Outcome.

Authors:  Samyuktha Lakkireddy; Sangeetha Aula; Atya Kapley; A V N Swamy; Raghunadha Rao Digumarti; Vijay Kumar Kutala; Kaiser Jamil
Journal:  Mol Diagn Ther       Date:  2016-02       Impact factor: 4.074

3.  Evaluation of Bone Marrow Microvessel Density in Patients with Aplastic Anemia.

Authors:  Venkatesan Somasundaram; Manvir Singh Tevatia; Abhishek Purohit; Ankur Ahuja; Manoranjan Mahapatra; Seema Tyagi; Haraprasad Pati; Renu Saxena
Journal:  Indian J Hematol Blood Transfus       Date:  2016-07-19       Impact factor: 0.900

4.  Evaluation of angiogenesis and vascular endothelial growth factor expression in the bone marrow of patients with aplastic anemia.

Authors:  Wolfgang Füreder; Maria-Theresa Krauth; Wolfgang R Sperr; Karoline Sonneck; Ingrid Simonitsch-Klupp; Leonhard Müllauer; Michael Willmann; Hans-Peter Horny; Peter Valent
Journal:  Am J Pathol       Date:  2006-01       Impact factor: 4.307

5.  CD44 is a RAS/STAT5-regulated invasion receptor that triggers disease expansion in advanced mastocytosis.

Authors:  Niklas Mueller; Daniel Wicklein; Gregor Eisenwort; Mohamad Jawhar; Daniela Berger; Gabriele Stefanzl; Georg Greiner; Alexandra Boehm; Christoph Kornauth; Leonhard Muellauer; Susanne Sehner; Gregor Hoermann; Wolfgang R Sperr; Philipp B Staber; Ulrich Jaeger; Johannes Zuber; Michel Arock; Udo Schumacher; Andreas Reiter; Peter Valent
Journal:  Blood       Date:  2018-07-17       Impact factor: 22.113

6.  VEGF concentration from plasma-activated platelets rich correlates with microvascular density and grading in canine mast cell tumour spontaneous model.

Authors:  R Patruno; N Arpaia; C D Gadaleta; L Passantino; N Zizzo; A Misino; N M Lucarelli; A Catino; P Valerio; D Ribatti; G Ranieri
Journal:  J Cell Mol Med       Date:  2008-04-18       Impact factor: 5.310

7.  c-Kit expression, angiogenesis, and grading in canine mast cell tumour: a unique model to study c-Kit driven human malignancies.

Authors:  Rosa Patruno; Ilaria Marech; Nicola Zizzo; Michele Ammendola; Patrizia Nardulli; Claudia Gadaleta; Marcello Introna; Gennaro Capriuolo; Rosa Angela Rubini; Domenico Ribatti; Cosmo Damiano Gadaleta; Girolamo Ranieri
Journal:  Biomed Res Int       Date:  2014-05-12       Impact factor: 3.411

8.  Vascular endothelial growth factors and angiopoietins as new players in mastocytosis.

Authors:  Simone Marcella; Angelica Petraroli; Mariantonia Braile; Roberta Parente; Anne Lise Ferrara; Maria Rosaria Galdiero; Luca Modestino; Leonardo Cristinziano; Francesca Wanda Rossi; Gilda Varricchi; Massimo Triggiani; Amato de Paulis; Giuseppe Spadaro; Stefania Loffredo
Journal:  Clin Exp Med       Date:  2021-03-09       Impact factor: 3.984

9.  Sphingosine-1-Phosphate/Sphingosine-1-Phosphate Receptor 2 Axis Can Promote Mouse and Human Primary Mast Cell Angiogenic Potential through Upregulation of Vascular Endothelial Growth Factor-A and Matrix Metalloproteinase-2.

Authors:  Alena Chumanevich; Piper Wedman; Carole A Oskeritzian
Journal:  Mediators Inflamm       Date:  2016-01-14       Impact factor: 4.711

Review 10.  Cytokine Regulation of Microenvironmental Cells in Myeloproliferative Neoplasms.

Authors:  Gregor Hoermann; Georg Greiner; Peter Valent
Journal:  Mediators Inflamm       Date:  2015-10-12       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.